Atıf İçin Kopyala
Martino M., Lanza F., DEMİRER T., Moscato T., Secondino S., Pedrazzoli P.
EXPERT OPINION ON BIOLOGICAL THERAPY, cilt.15, sa.2, ss.195-211, 2015 (SCI-Expanded)
-
Yayın Türü:
Makale / Derleme
-
Cilt numarası:
15
Sayı:
2
-
Basım Tarihi:
2015
-
Doi Numarası:
10.1517/14712598.2015.971749
-
Dergi Adı:
EXPERT OPINION ON BIOLOGICAL THERAPY
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus
-
Sayfa Sayıları:
ss.195-211
-
Anahtar Kelimeler:
allogeneic hematopoietic stem cell transplant, autologous hematopoietic stem cell transplant, erythropoiesis-stimulating agents, erythropoietin, RECOMBINANT-HUMAN-ERYTHROPOIETIN, BONE-MARROW-TRANSPLANTATION, QUALITY-OF-LIFE, CLINICAL-PRACTICE GUIDELINE, CHEMOTHERAPY-INDUCED ANEMIA, EPOETIN-ALPHA, CANCER-PATIENTS, PERIPHERAL-BLOOD, DARBEPOETIN-ALPHA, INTRAVENOUS IRON
-
Ankara Üniversitesi Adresli:
Evet
Özet
Introduction: Erythropoiesis-stimulating agents (ESAs) are used in treating cancer- and chemotherapy-induced anemia with the aim of accelerating the recovery of red blood cells (RBCs), reduce the risks associated with RBC transfusions and improve quality of life.